These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [The efficacy of eculizumab against post-thymectomy exacerbations in thymoma associated myasthenia gravis (MG)]. Author: Takeuchi E, Kajiyama Y, Ando K, Funaki S, Okuno T, Shintani Y, Mochizuki H. Journal: Rinsho Shinkeigaku; 2022 Apr 27; 62(4):277-280. PubMed ID: 35354724. Abstract: We report a 62-year-old woman with thymoma associated myasthenia gravis (MG). She had significant dysphagia and was treated with corticosteroids, intravenous immunoglobulin (IVIG), immunoadsorption plasmapheresis (IAPP), and immunosuppressive drugs, and the extended thymectomy. Her symptoms gradually improved, but 3 weeks after thymectomy, her bulbar symptoms recurred. Although she was treated with repeated IVIG and IAPP, her symptom remained. Finally, after starting eculizumab did her symptoms go into complete remission. This case suggests the efficacy of anti-complement therapy for postoperative exacerbation of MG.[Abstract] [Full Text] [Related] [New Search]